Healthcare / Medical DistributionShenzhen
$23.39
-0.23 (-0.97%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.6B · quality 81.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$13.0B
P/E
11.9x
↓EV/EBITDA
3.1x
↓ROE
6.1%
↑Gross Margin
10.7%
↓Debt/Equity
0.23
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-0.0%
FCF CAGR
-14.0%
FCF margin
1.9%
FCF / Net income
1.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $73.42B · net income $1.14B · FCF $1.42B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $73.42B | $73.42B | $74.38B | $75.48B | $73.44B |
| Net Income | $1.14B | $1.14B | $642.5M | $1.60B | $1.49B |
| EBITDA | $3.06B | $3.06B | $2.49B | $4.15B | $3.88B |
| EPS | 2.04 | 2.04 | 1.15 | 2.87 | 2.67 |
| Gross Margin | 10.7% | 10.7% | 11.1% | 12.0% | 12.2% |
| Operating Margin | 2.5% | 2.5% | 2.3% | 3.3% | 3.3% |
| Net Margin | 1.5% | 1.5% | 0.9% | 2.1% | 2.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.23 | 0.23 | 0.30 | 0.29 | 0.22 |
| Current Ratio | 1.56 | 1.56 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.42B | $1.42B | $2.99B | $2.61B | $2.24B |
| Returns | |||||
| ROE | 6.1% | 6.1% | 3.6% | 9.2% | 9.2% |
| Valuation | |||||
| P/E | 11.87 | 11.87 | 22.79 | 10.15 | 9.87 |
| EV/EBITDA | 3.10 | 3.10 | 5.04 | 3.57 | 3.14 |
| P/B | 0.70 | 0.70 | 0.83 | 0.93 | 0.91 |
| Growth & Yield | |||||
| Revenue Growth | -1.3% | -1.3% | -1.5% | 2.8% | — |
| EPS Growth | 77.4% | 77.4% | -59.9% | 7.5% | — |
| Dividend Yield | 1.6% | 1.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
0.6%
EPS terminal req.
$2.08
Spread vs growth
76.8%
5Y implied EPS CAGR
4.2%
EPS terminal req.
$2.51
Spread vs growth
73.1%
10Y implied EPS CAGR
7.1%
EPS terminal req.
$4.04
Spread vs growth
70.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-6.7%
Start / end P/E
22.2x → 11.5x
EPS bridge
1.15 → 2.04
Residual
-37.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.